Domestic drugmaker CSPC Pharmaceutical Group said on Wednesday that its messenger RNA COVID-19 vaccine has gained emergency use authorization from China's top drug regulator.
The vaccine, named SYS6006, is designed to target the BA.5 variant of Omicron, the company said in a statement released on its website.
It is the first mRNA vaccine to be approved for use on the Chinese mainland. The drug was approved for clinical trials in April last year. So far, it has gone through the first two trial phases, and research on its effectiveness as a booster shot has been completed.
Trials involving over 5,500 participants have confirmed its safety, immunogenicity and protective effects, the company said.
The incidence rate and severity of adverse reactions among younger participants was much higher than among the elderly, it added.
When a dose of SYS6006 was delivered as a booster shot to people who had been vaccinated with two or three doses of inactivated vaccines, it demonstrated good protective effects against multiple variants, including BA.5, BF.7, BQ.1.1, XBB.1.5 and CH.1.1.
Research data also show that the vaccine can induce T cell memory response against different variants, including Delta and the BA.2 and BA.5 Omicron variants.
The product should be stored at temperatures between 2 to 8 C.
By the end of last year, China had granted conditional market approval to five COVID-19 vaccines and emergency use approval to eight vaccines.
- Nation approves first mRNA COVID-19 vaccine
- Canada to drop mandatory COVID-19 tests for travelers from China
- China’s new plan for handling COVID-19 brings tourism resurgence to the border
- China promotes booster shots with variety of vaccine choices
- More elderly get COVID vaccine jabs
- Beijing, Tianjin provide aerosolized vaccine as booster shots
Popular Videos
Hot comments
- China Life: Chinese women shine with She Power
- First apes at U.S. zoo receive COVID-19 vaccine made for animals, zoo official says
- 86-year-old grandma in Hebei spends most her life on traditional cheongsam
- Lantern Festival: A romantic celebration in China
- Homemade curling videos trending in China
- Seven things you may not know about Lantern Festival
- Veteran free skier Xu wins gold in women’s aerials at Beijing 2022
- China’s only captive male manul dies of choking
- China eases Covid travel-tracking requirements
- 16 Hours in Guilin
Top Reviews
- Nation approves first mRNA COVID-19 vaccine
- Guiyang-Nanning HSR installs sound, light barriers to protect ecology
- Thousands of lanterns bring light to Baiku Yao people
- Guangxi, South Korea to boost medical cosmetology cooperation
- Guangxi reaches out in Europe for more business cooperation
- County in south China manages water deficit through various measures
- Xi leaves for China after state visit to Russia
- Xi, Putin jointly meet the press
- Xi, Putin vow to deepen strategic partnership in fruitful talks
- Ambassadors thumb up fantastic Chinese sceneries at 2023 Discovering China